Pharmaceuticals firm Ascendis Health’s offer of 80c a share to buy out shareholders and delist the firm is fair, even if leaked and disputed information is taken into account.
That is according to a new report by financial advisory firm BDO, a copy of which is in Business Day’s possession. The report was commissioned by the Ascendis board after ousted chair Harry Smit published a presentation on X (formerly Twitter), which revealed that insiders believe the firm was worth far more than the offer to minorities...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.